The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (4 analysts) rates it none, with a mean price target of $16.
Chicago Atlantic Real Estate Finance Inc
REFI · USD · Market cap $226M
Chicago Atlantic Real Estate Finance, Inc.
FAIL · Does not pass the screenAt the last full screen
2025-12-31
Screened 2025-12-31 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Chicago Atlantic Real Estate Finance Inc holds its Accumulation at $10.62. Elevated stress, defensive posture warranted, held for 16 days.
| Phase | Accumulation |
| Quantitative state | Elevated stress, defensive posture warranted, held for 16 days |
| Price at the screen | $10.62 |
| Valuation | 7.37 trailing · 5.53 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.31 |
Five Screens, Shown in Full
Does not pass. Business activity: conventional financial services
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Its core business involves an activity the values screen does not clear. | Fail |
| Debt load | 23.17% | Below 33% | Interest-bearing debt is just 23.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 4.46% | Below 49% | Money owed to the company is 4.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 113.29% | Below 5% | 113.3% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2025-12-31 screen. The gold marker is the market price at the same screen. A 88.3% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +51% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2025-12-31 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 5.5xvery cheap relative to earnings |
| Trailing P/E | 7.4xvery cheap relative to earnings |
| EPS, trailing | 1.44 |
| EPS, forward | 1.92 |
| Revenue growth | -34.2%revenue is shrinking |
| Profit margin | 61.8%highly profitable on every dollar of sales |
| Return on equity | 10.0%a modest return on shareholder capital |
| Dividend yield | 1,653.00% |
| Debt to equity | 0.38minimal debt: a conservative balance sheet |
| Current ratio | 30.37comfortably covers its short-term bills |
| Beta | 0.31barely tracks the market's swings |
| Short interest, float | 0.06% |
| 52-week range | 10.56 - 14.57 |
| Moat | NONE |
| Market cap | $226M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (4 analysts) rates it none, with a mean price target of $16.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (4 analysts) rates it none, with a mean price target of $16.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $11.58 | -1.7% | · | $983 | -1.7% |
| 2 months | $11.51 | -1.1% | · | $989 | -1.1% |
| 3 months | $11.60 | -1.9% | $0.47 | $1,021 | +2.1% |
| 6 months | $12.13 | -6.2% | $0.94 | $1,016 | +1.6% |
| 1 year | $12.24 | -7.1% | $1.88 | $1,083 | +8.3% |
| 2 years | $11.82 | -3.7% | $3.94 | $1,296 | +29.6% |
| 3 years | $10.06 | +13.2% | $6.11 | $1,739 | +73.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever REFI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.